|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,654.00 JPY | +0.30% |
|
+0.39% | +4.16% |
| 03-10 | Glass Lewis Controversy Alert: Kobayashi Pharmaceutical | MT |
| 03-05 | Oasis Management Company Urges Shareholders to Oppose Kobayashi Pharma?s Transition | CI |
| Capitalization | 419B 2.63B 2.3B 2.07B 1.98B 3.61B 243B 3.75B 24.77B 9.82B 116B 9.85B 9.64B | P/E ratio 2025 |
110x | P/E ratio 2026 * | 36.7x |
|---|---|---|---|---|---|
| Enterprise value | 360B 2.25B 1.97B 1.78B 1.7B 3.1B 208B 3.22B 21.26B 8.42B 99.56B 8.45B 8.28B | EV / Sales 2025 |
2.43x | EV / Sales 2026 * | 2.05x |
| Free-Float |
60.58% | Yield 2025 |
1.92% | Yield 2026 * | 1.87% |
| 1 day | +0.30% | ||
| 1 week | +0.39% | ||
| Current month | -3.02% | ||
| 1 month | +2.11% | ||
| 3 months | +7.47% | ||
| 6 months | +0.84% | ||
| Current year | +4.16% |
| 1 week | 5,520 |  | 5,706 |
| 1 month | 5,486 | | 5,839 |
| Current year | 5,251 | | 5,839 |
| 1 year | 4,850 | | 5,885 |
| 3 years | 4,700 | | 8,600 |
| 5 years | 4,700 | | 10,880 |
| 10 years | 4,205 | | 13,120 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 54 | 2013-05-31 | |
Noriaki Hirao
IRC | Investor Relations Contact | - | - |
Kenji Kohori
SAM | Sales & Marketing | 71 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 2004-05-31 | |
Kunio Ito
BRD | Director/Board Member | 74 | 2013-05-31 |
Kaori Sasaki
BRD | Director/Board Member | 66 | 2016-05-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +10.82% | 1.19% | 7 M€ | |
| -0.08% | 0.21% | 12 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.30% | +0.39% | -0.98% | -29.06% | 2.63B | |
| +0.10% | -1.94% | -10.31% | +6.22% | 350B | |
| +0.15% | -2.04% | -5.35% | +6.36% | 139B | |
| +1.01% | -5.04% | -1.09% | +21.82% | 71.21B | |
| +1.08% | -2.95% | -0.68% | -10.23% | 60.36B | |
| +0.58% | -4.89% | -23.32% | - | 33.52B | |
| +4.26% | -5.22% | +32.11% | -62.89% | 31.79B | |
| -0.48% | -6.73% | -41.48% | -29.81% | 19.61B | |
| +0.54% | -0.76% | -12.23% | -6.51% | 18.97B | |
| -2.32% | -7.94% | +0.20% | +13.28% | 11.37B | |
| Average | +0.52% | -3.71% | -6.31% | -10.09% | 73.91B | |
| Weighted average by Cap. | +0.44% | -2.80% | -7.15% | +1.94% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 165B 1.04B 906M 818M 783M 1.42B 95.82B 1.48B 9.77B 3.87B 45.78B 3.89B 3.81B | 174B 1.09B 954M 862M 824M 1.5B 101B 1.56B 10.3B 4.08B 48.23B 4.1B 4.01B |
| Net income | 11.57B 72.46M 63.34M 57.23M 54.74M 99.57M 6.7B 104M 684M 271M 3.2B 272M 266M | 11.29B 70.76M 61.85M 55.88M 53.45M 97.22M 6.54B 101M 668M 265M 3.13B 266M 260M |
| Net Debt | -59.44B -372M -326M -294M -281M -512M -34.45B -532M -3.51B -1.39B -16.46B -1.4B -1.37B | -62.23B -390M -341M -308M -295M -536M -36.06B -557M -3.68B -1.46B -17.23B -1.46B -1.43B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-15 | 5,654.00 ¥ | +0.30% | 69,800 |
| 26-03-13 | 5,637.00 ¥ | +1.51% | 183,800 |
| 26-03-12 | 5,553.00 ¥ | -1.72% | 189,200 |
| 26-03-11 | 5,650.00 ¥ | +0.71% | 110,300 |
| 26-03-10 | 5,610.00 ¥ | -0.39% | 206,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4967 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition